Home›Stock Screener›Adline Chem Lab›Quarterly Results

Adline Chem Lab Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-4 Cr
QMarch 2023
Quarterly Results

In 2026, Adline Chem Lab (ADLINE) reported revenue ₹0 Cr and net profit ₹0 Cr. Analyse ADLINE shareholding pattern to track promoter, FII and institutional holdings.

ADLINE Quarterly Results — Revenue, Profit & EPS Highlights

Adline Chem Lab latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Check Adline Chem Lab marketcap in USD to track the company's total market size over time.

  • Revenue of ₹1 Cr in March 2023 (+0.0% vs March 2022)
  • Net Profit of ₹-4 Cr in March 2023 (-500.0% vs March 2022)
  • Earnings Per Share of ₹-7.24 in March 2023 (-3347.6% vs March 2025)

Adline Chem Lab Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ADLINE quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 0 0 1 1 - -
Net Profit (₹ Cr) 0 0 0 -4 1 - -
EBITDA (₹ Cr) 0 0 0 0 0 - -
EPS (₹) 0.00 -0.21 -0.46 -7.24 1.23 - -
Operating Margin (%) 0.0% 0.0% 0.0% 0.0% -40.0% - -

ADLINE Share Price Trend — 1-Year Movement Across Quarterly Results

Adline Chem Lab 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit Adline Chem Lab stock price NSE.

Profitability Ratios

Profit Margin -400.0%

Balance Sheet Highlights

Total Assets ₹0 Cr
Total Equity ₹-2 Cr
Current Assets ₹0 Cr
Current Liabilities ₹2 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹0 Cr

Revenue Trend (₹ Cr)

March 2023 1
March 2024 0
March 2025 0
2026 0

Net Profit Trend (₹ Cr)

March 2023 -4
March 2024 0
March 2025 0
2026 0

Operating Margin Trend (%)

March 2023 0.0%
March 2024 0.0%
March 2025 0.0%
2026 0.0%

ADLINE vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Adline Chem Lab latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹463,071.60 Cr 1902.4 15,018 2,710 -5.6% - 18.0% 168.4
Divis Laboratories
Mar 2026 		₹225,157.18 Cr 8597.0 2,986 751 -5.0% - 25.2% 303.7
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4896.5 4,111 364 +27.7% +42.2% 8.9% 425.4
Cipla
Mar 2026 		₹115,699.61 Cr 1432.2 6,612 543 -9.3% - 8.2% 208.5
Zydus Life Science
Mar 2026 		₹113,855.38 Cr 1120.0 7,569 1,341 -4.3% - 17.7% 88.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores